KOPIN CORP, 10-Q filed on 5/10/2018
Quarterly Report
v3.8.0.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2018
May 07, 2018
Document Documentand Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q1  
Trading Symbol KOPN  
Entity Registrant Name KOPIN CORP  
Entity Central Index Key 0000771266  
Current Fiscal Year End Date --12-29  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   76,529,535
v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2018
Dec. 30, 2017
Current assets:    
Cash and cash equivalents $ 24,167,900 $ 24,848,227
Marketable debt securities, at fair value 36,873,595 43,907,457
Accounts receivable, net of allowance of $273,000 in 2018 and $149,000 in 2017 2,457,904 3,955,123
Contract with Customer, Asset, Net 2,479,062 704,863
Inventory 3,773,305 5,080,797
Prepaid taxes 102,462 264,352
Prepaid expenses and other current assets 1,155,303 978,677
Total current assets 71,009,531 79,739,496
Property, plant and equipment, net 5,304,135 5,077,043
Goodwill 1,801,988 1,780,247
Finite-Lived Intangible Assets, Net 662,727 883,636
Other assets 4,194,219 3,842,068
Financial Instruments, Owned, at Fair Value 3,900,000  
Total assets 86,872,600 91,322,490
Current liabilities:    
Accounts payable 3,210,639 4,918,605
Accrued payroll and expenses 1,920,873 1,636,512
Accrued warranty 599,000 649,000
Contract with Customer, Liability 384,073 896,479
Other accrued liabilities 2,106,782 2,066,025
Income tax payable 0 1,416,892
Deferred tax liabilities 523,529 520,000
Total current liabilities 8,744,896 12,103,513
Deferred Revenue, Noncurrent 262,207 374,171
Asset retirement obligations 280,348 269,877
Liabilities, Other than Long-term Debt, Noncurrent 1,484,713 1,195,082
Stockholders’ equity:    
Preferred stock, par value $.01 per share: authorized, 3,000 shares; none issued 0 0
Common stock, par value $.01 per share: authorized, 120,000,000 shares; issued 81,046,313 shares in 2018 and 80,201,313 shares in 2017; outstanding 73,078,783 shares in 2018 and 73,058,783 shares in 2017 775,920 775,720
Additional paid-in capital 332,518,555 331,119,340
Treasury stock (4,513,256 shares in 2018 and 2017, at cost) (17,238,669) (17,238,669)
Accumulated other comprehensive income 3,294,916 3,564,779
Accumulated deficit (242,598,797) (240,121,901)
Total Kopin Corporation stockholders’ equity 76,751,925 78,099,269
Noncontrolling interest (651,489) (719,422)
Total stockholders’ equity 76,100,436 77,379,847
Total liabilities and stockholders’ equity $ 86,872,600 $ 91,322,490
v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Mar. 31, 2018
Dec. 30, 2017
Statement of Financial Position [Abstract]    
Accounts receivable, allowance $ 273,000 $ 149,000
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, authorized 3,000 3,000
Preferred stock, issued 0 0
Common stock, par value $ 0.01 $ 0.01
Common stock, authorized 120,000,000 120,000,000
Common stock, issued 81,046,313 80,201,313
Common stock, outstanding 73,078,783 73,058,783
Treasury stock, shares 4,513,256 4,513,256
v3.8.0.1
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2018
Apr. 01, 2017
Revenues:    
Net product revenues $ 5,044,809 $ 3,933,142
Research and development revenues 608,811 444,985
Total revenues 5,653,620 4,378,127
Expenses:    
Cost of product revenues 4,062,191 3,117,357
Research and development 4,451,653 4,281,870
Selling, general and administration 6,931,410 5,641,684
Total expenses 15,445,254 13,040,911
Loss from operations (9,791,634) (8,662,784)
Other income and expense:    
Interest income 159,851 233,777
Other income 1,101,255 534,411
Foreign currency transaction gains (losses) 208,608 (1,191,283)
Gain on investments 2,849,816 0
Total other income and expense 4,319,530 (423,095)
Loss before (provision) benefit for income taxes and net loss (income) attributable to noncontrolling interest (5,472,104) (9,085,879)
Tax benefit 0 1,146,000
Net loss (5,472,104) (7,939,879)
Net (income) loss attributable to noncontrolling interest (64,174) 81,438
Net loss attributable to the controlling interest $ (5,536,278) $ (7,858,441)
Net (loss) income per share    
Basic and diluted (usd per share) $ (0.08) $ (0.12)
Weighted average number of common shares    
Basic and diluted (in shares) 73,078,344 64,538,686
v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
3 Months Ended
Mar. 31, 2018
Apr. 01, 2017
Statement of Comprehensive Income [Abstract]    
Net loss $ (5,472,104) $ (7,939,879)
Other comprehensive (loss) income, net of tax:    
Foreign currency translation adjustments (124,480) 1,597,406
Unrealized holding losses on marketable securities (136,874) (11,314)
Reclassification of holding losses in net loss (4,750) (1,156)
Other comprehensive (loss) income, net of tax (266,104) 1,584,936
Comprehensive loss (5,738,208) (6,354,943)
Comprehensive (income) loss attributable to the noncontrolling interest (67,933) 58,034
Comprehensive loss attributable to controlling interest $ (5,806,141) $ (6,296,909)
v3.8.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - 3 months ended Mar. 31, 2018 - USD ($)
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income
Accumulated Deficit
Total Kopin Corporation Stockholders’ Equity
Noncontrolling Interest
Beginning balance at Dec. 30, 2017 $ 77,379,847 $ 775,720 $ 331,119,340 $ (17,238,669) $ 3,564,779 $ (240,121,901) $ 78,099,269 $ (719,422)
Beginning Balance (in shares) at Dec. 30, 2017   77,572,038            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation 1,399,415   1,399,415       1,399,415  
Vesting of restricted stock (shares)   20,000            
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures   $ 200 (200)          
Other comprehensive (loss) income (266,104)       (269,863)   (269,863) 3,759
Gain (Loss) on Sale of Treasury Stock 3,059,382           3,059,382  
Net loss (5,472,104)         (5,536,278) (5,536,278) 64,174
Ending balance at Mar. 31, 2018 $ 76,100,436 $ 775,920 $ 332,518,555 $ (17,238,669) $ 3,294,916 $ (242,598,797) $ 76,751,925 $ (651,489)
Ending Balance (in shares) at Mar. 31, 2018   77,592,038            
v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Mar. 31, 2018
Apr. 01, 2017
Cash flows from operating activities:    
Net loss $ (5,472,104) $ (7,939,879)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization 554,967 443,174
Stock-based compensation 1,399,415 1,292,105
Foreign currency (gains) losses (218,943) 1,190,199
Provision for Doubtful Accounts (136,095) 0
Unrealized gain on investments (2,849,816) (274,000)
Deferred income taxes 0 (1,168,962)
Other non-cash items 442,691 157,140
Changes in assets and liabilities, net of acquired assets and liabilities:    
Accounts receivable 1,461,884 (210,823)
Increase (Decrease) in Cost in Excess of Billing on Uncompleted Contract 1,124,634 0
Inventory (198,961) (249,340)
Prepaid expenses and other current assets 98,008 (22,082)
Accounts payable and accrued expenses (2,644,054) 10,736
Billings in excess of revenue earned 379,330 152,797
Net cash used in operating activities (6,059,044) (6,618,935)
Cash flows from investing activities:    
Other assets (87,632) (12,346)
Capital expenditures (553,793) (297,983)
Proceeds from sale of marketable debt securities 6,909,855 13,519,291
Payments to Acquire Equity Method Investments (1,000,000) 0
Purchase of marketable debt securities 0 (948,637)
Cash paid for acquisition, net of cash acquired 0 (3,247,397)
Net cash provided by investing activities 5,268,430 9,012,928
Cash flows from financing activities:    
Effect of exchange rate changes on cash 110,287 176,578
Net (decrease) increase in cash and cash equivalents (680,327) 2,570,571
Cash and equivalents:    
Beginning of period 24,848,227 18,393,066
End of period 24,167,900  
Supplemental disclosure of cash flow information:    
Income taxes paid $ 1,429,000 $ 0
v3.8.0.1
BASIS OF PRESENTATION
3 Months Ended
Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF PRESENTATION
BASIS OF PRESENTATION
The condensed consolidated financial statements of Kopin Corporation (the Company) as of March 31, 2018 and for the three month periods ended March 31, 2018 and April 1, 2017 are unaudited and include all adjustments which, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the year ended December 30, 2017. The results of the Company's operations for any interim period are not necessarily indicative of the results of the Company's operations for any other interim period or for a full fiscal year. The Company reclassified certain prior period amounts to conform to the current period presentation.
v3.8.0.1
ACCOUNTING STANDARDS (Notes)
3 Months Ended
Mar. 31, 2018
Revenue, Initial Application Period Cumulative Effect Transition [Abstract]  
Basis of Presentation and Significant Accounting Policies [Text Block]
2.
ACCOUNTING STANDARDS
Recently Issued Accounting Pronouncements
Leases    
In February 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-02 (Topic 842) Leases, which requires lessees to recognize a right-of-use asset and lease liability for most lease arrangements. The new standard is effective for fiscal years beginning after December 15, 2018, with early adoption permitted, and must be adopted using the modified retrospective approach. The Company intends to adopt the standard on the effective date of December 30, 2018. The Company is currently evaluating the potential changes from this ASU to its future financial reporting and disclosures and designing and implementing related processes and controls.
Recently Adopted Accounting Pronouncements
Recognition and Measurement of Financial Assets and Liabilities
The Company adopted ASU No. 2016-01 and the related amendments on December 31, 2017 (the first day of the Company's fiscal year 2018). This standard amends various aspects of the recognition, measurement, presentation, and disclosure of financial instruments. The Company adopted the measurement alternative for equity investments without readily determinable fair values (often referred to as cost method investments) on a prospective basis. As a result, these investments will be revalued upon occurrence of an observable price change for similar investments and for impairments. The Company expects that the adoption of this guidance may have a material effect on its financial statements on an ongoing basis.
Revenue from Contracts with Customers
The Company adopted ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) effective December 31, 2017 and applied the modified retrospective method. The Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The Company expects the impact of the adoption of the new standard to be material to the Company's results of operations on an ongoing basis.
Significant Accounting Policies Update
The Company's significant accounting policies are detailed in "Note 1: Summary of Significant Accounting Policies" of our Annual Report on Form 10-K for the year ended December 30, 2017. Significant changes to the Company's accounting policies as a result of adopting Topic 606 are discussed below.
Revenue Recognition
The vast majority of our revenues are from orders received from our customers for the purchase of wearable technology components which can be integrated to create headset systems. We also have development contracts for the design, manufacture and modification of products for the U.S. government or a prime contractor for the U.S. government (“U.S. government”) or for a customer that sells into the industrial or consumer markets. The Company's contracts with the U.S. government are typically subject to the Federal Acquisition Regulations (“FAR”) and are priced based on estimated or actual costs of producing goods. The FAR provides guidance on the types of costs that are allowable in establishing prices for goods provided under U.S. government contracts. The pricing for non-U.S. government contracts is based on the specific negotiations with each customer.
Our fixed-price contracts with the U.S. government may result in revenue recognized in excess of amounts actually billed. We present the in excess of revenues over amounts actually billed as Contract assets on the balance sheet. Amounts billed and due from our customers are classified as receivables on the balance sheet. In some instances, the U.S. government retains a small portion of the contract price until completion of the contract. The portion of the payments retained until final contract settlement is not considered a significant financing component because the intent is to protect the customer. For contracts with the U.S. government, we typically receive interim payments either as work progresses, we achieve certain milestones or based on a schedule in the contract. We recognize a liability for these advance payments in excess of revenue recognized and present it as billings in excess of revenue recognized on the balance sheet. The advanced payment typically is not considered a significant financing component because it is used to meet working capital demands that can be higher in the early stages of a contract and to protect us from the other party failing to adequately complete some or all of its obligations under the contract. For industrial and consumer purchase orders, we typically receive payments within 30 to 60 days of shipments of the product, although for some purchase orders, we may require an advanced payment prior to shipment of the product.
To determine the proper revenue recognition method for complex contracts with the same customer, we evaluate whether two or more contracts should be combined and accounted for as one single contract and whether the combined or single contract should be accounted for as more than one performance obligation. This evaluation requires significant judgment and the decision to combine a group of contracts or separate the combined or single contract into multiple performance obligations could change the amount of revenue and profit recorded in a given period. For most of our development contracts and contracts with the U.S government, the customer contracts with us to provide a significant service of integrating a set of components into a single unit. Hence, the entire contract is accounted for as one performance obligation. Less common, however, we may promise to provide distinct goods or services within a contract in which case we separate the contract into more than one performance obligation. If a contract is separated into more than one performance obligation, we allocate the total transaction price to each performance obligation in an amount based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. In cases where we sell standard products, the observable standalone sales are used to determine the standalone selling price.
The Company recognizes revenue from a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. For certain contracts that meet the foregoing requirements, primarily international direct commercial and military sale contracts, we recognize revenue once we have obtained all regulatory approvals.
Commencing in 2018 for certain contracts with the U.S. government, the Company recognizes revenue over time as we perform because of continuous transfer of control to the customer and the lack of an alternative use for the product. The continuous transfer of control to the customer is supported by liability clauses in the contract that allow the U.S. government to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit and take control of any work in process. For contracts with commercial customers while the contract may have similar liability clause our products historically have an alternative use and thus, revenue is recognized at a point in time.
In situations where control transfers over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. We generally use the cost-to-cost approach to measure the extent of progress towards completion of the performance obligation for our contracts because we believe it best depicts the transfer of assets to the customer which occurs as we incur costs on our contracts. Under the cost-to-cost measure approach, the extent of progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation. Revenues are recorded proportionally as costs are incurred.
Accounting for design, development and production contracts requires judgment relative to assessing risks, estimating contract revenues and costs, and making assumptions for schedule and technical issues. Due to the size and nature of the work required to be performed on many of our contracts, the estimation of total revenue and cost at completion is complicated and subject to many variables. Contract costs include material, labor and subcontracting costs, as well as an allocation of indirect costs. We have to make assumptions regarding the number of labor hours required to complete a task, the complexity of the work to be performed, the availability and cost of materials, and performance by our subcontractors. For contract change orders, claims or similar items, we apply judgment in estimating the amounts and assessing the potential for realization. These amounts are only included in contract value when they can be reliably estimated and realization is considered probable. If our estimate of total contract costs or our determination of whether the customer agrees that a milestone is achieved is incorrect, our revenue could be overstated or understated and the profits or loss reported could be wrong.
For our commercial customers, the Company's revenue is recognized when obligations under the terms of a contract with our customer is satisfied; generally this occurs with the transfer of control of the Company's products or services. Revenue is recorded as the amount of consideration we expect to receive in exchange for transferring goods or providing services. Provisions for product returns and allowances are recorded in the same period as the related revenues. We analyze historical returns, current economic trends and changes in customer demand and acceptance of product when evaluating the adequacy of sales returns and other allowances. Certain product sales are made to distributors under agreements allowing for a limited right of return on unsold products. Sales to distributors are primarily made for sales to the distributors' customers and not for stocking of inventory. We delay revenue recognition for our estimate of distributor claims of right of return on unsold products based upon our historical experience with our products and specific analysis of amounts subject to return based upon discussions with our distributors or their customers. Sales, value add and other taxes we collect concurrent with revenue-producing activities are excluded from revenue.
The rights and benefits to the Company's intellectual property are conveyed to certain customers through technology license agreements. These agreements may include other performance obligations including the sale of product to the customer. When the license is distinct from other obligations in the agreement, the Company treats the license and other performance obligations as separate performance obligations. Accordingly, the license is recognized at a point in time or over time based on the standalone selling price. The sale of materials are recognized at a point in time, which occurs with the transfer of control of the Company's products or services. In certain instances, the Company is entitled to sales-based royalties under license agreements. These sales-based royalties are recognized when they are earned.
The cumulative effect of the changes made to the Company's consolidated December 31, 2017 balance sheet for the adoption of ASU 2014-09, Revenue from Contracts with Customers (Topic 606) was as follows:
Balance Sheet
Balance at December 30, 2017
 
Adjustments due to ASC 606
 
Balance at December 31, 2017
Assets
 
 
 
 
 
Contract assets and unbilled receivables
$
704,863

 
$
2,850,274

 
$
3,555,137

Inventory
5,080,797

 
(1,082,629
)
 
3,998,168

Other assets
3,842,068

 
400,000

 
4,242,068

 
 
 
 
 
 
Liabilities
 
 
 
 
 
Contract liabilities and billings in excess of revenue earned
896,479

 
(891,737
)
 
4,742

 
 
 
 
 
 
Stockholders’ equity
 
 
 
 
 
Accumulated Deficit
$
(240,121,901
)
 
$
3,059,382

 
$
(237,062,519
)
In accordance with the new revenue standard requirements, the impact of adoption on the Company's condensed consolidated statement of operations and condensed balance sheets was as follows:
 
For the period ended March 31, 2018
Statement of Operations
As Reported
 
Balances Without Adoption of
ASC 606
 
Effect of Change Higher/(Lower)
Net product revenues
$
5,044,809

 
$
6,505,343

 
$
(1,460,534
)
Research and development revenues
608,811

 
695,355

 
(86,544
)
Cost of product revenues
4,062,191

 
5,069,765

 
(1,007,574
)
Net loss attributable to the controlling interest
$
(5,536,278
)
 
$
(4,996,773
)
 
$
(539,505
)
 
For the period ended March 31, 2018
Balance Sheet
As Reported
 
Balances Without Adoption of
ASC 606
 
Effect of Change Higher/(Lower)
Assets
 
 
 
 
 
Contract assets and unbilled receivables
$
2,479,062

 
$
1,089,322

 
$
1,389,740

Inventory
3,773,305

 
3,848,359

 
(75,054
)
Other assets
4,194,219

 
3,794,219

 
400,000

 
 
 
 
 
 
Liabilities
 
 
 
 
 
Contract liabilities and billings in excess of revenue earned
384,073

 
1,189,266

 
(805,193
)
 
 
 
 
 
 
Stockholders’ equity
 
 
 
 
 
Accumulated deficit
$
(242,598,797
)
 
$
(245,082,132
)
 
$
2,483,335


See Note 11. Segments and Disaggregation of Revenue for additional information regarding the disaggregation of the Company's revenue by major source and the Company's updated accounting policy for revenue recognition.
Contract Assets
Contract assets include unbilled amounts typically resulting from sales under contracts when the cost-to-cost method of revenue recognition is utilized and revenue recognized exceeds the amount billed to the customer, and right to payment is not just subject to the passage of time. Amounts may not exceed their net realizable value. Contract assets are generally classified as current. The Company classifies the noncurrent portion of contract assets under other assets in its condensed consolidated balance sheets.
Contract Liabilities
Contract liabilities consist of advance payments and billings in excess of cost incurred and deferred revenue.
Remaining Performance Obligations
Remaining performance obligations represent the transaction price of firm orders for which work has not been performed and excludes unexercised contract options and potential orders under ordering-type contracts (e.g., indefinite-delivery, indefinite-quantity ("IDIQ")). As of March 31, 2018, the aggregate amount of the transaction price allocated to remaining performance obligations was $2.7 million. The Company expects to recognize revenue on the remaining performance obligations over the next 12 months.
v3.8.0.1
CASH AND EQUIVALENTS AND MARKETABLE SECURITIES
3 Months Ended
Mar. 31, 2018
Cash and Equivalents and Marketable Securities Disclosure [Abstract]  
CASH AND EQUIVALENTS AND MARKETABLE SECURITIES
CASH AND CASH EQUIVALENTS AND MARKETABLE SECURITIES
The Company considers all highly liquid, short-term debt instruments with original maturities of three months or less to be cash equivalents.
Marketable debt securities consist primarily of commercial paper, medium-term corporate notes, and U.S. government and agency backed securities. The Company classifies these marketable debt securities as available-for-sale at fair value in “Marketable debt securities, at fair value”. The Company records the amortization of premium and accretion of discounts on marketable debt securities in the results of operations.
The Company uses the specific identification method as a basis for determining cost and calculating realized gains and losses with respect to marketable debt securities. The gross gains and losses realized related to sales and maturities of marketable debt securities were not material during the three months ended March 31, 2018 and the year ended December 30, 2017.
Investments in available-for-sale marketable debt securities are as follows at March 31, 2018 and December 30, 2017
 
Amortized Cost

Unrealized Losses

Fair Value
 
2018

2017

2018

2017

2018

2017
U.S. government and agency backed securities
$
29,821,596


$
35,014,593


$
(403,318
)

$
(288,782
)

$
29,418,278


$
34,725,811

Corporate debt
7,270,853

 
8,988,608

 
(15,426
)
 
(7,702
)
 
7,255,427

 
8,980,906

Certificates of deposit
200,000


201,000


(110
)

(260
)

199,890


200,740

Total
$
37,292,449

 
$
44,204,201

 
$
(418,854
)
 
$
(296,744
)
 
$
36,873,595

 
$
43,907,457


The contractual maturity of the Company’s marketable debt securities is as follows at March 31, 2018:
 
Less than
One year
 
One to
Five years
 
Greater than
Five years
 
Total
U.S. government and agency backed securities
$
16,970,998

 
$
11,498,340

 
$
948,940

 
$
29,418,278

Corporate debt
1,041,720

 
6,213,707

 

 
7,255,427

Certificates of deposit
199,890

 

 

 
199,890

Total
$
18,212,608

 
$
17,712,047

 
$
948,940

 
$
36,873,595


The Company conducts a review of its marketable debt securities on a quarterly basis for the presence of other-than-temporary impairment ("OTTI"). The Company assesses whether OTTI is present when the fair value of a debt security is less than its amortized cost basis at the balance sheet date. Under these circumstances OTTI is considered to have occurred (1) if the Company intends to sell the security before recovery of its amortized cost basis; (2) if it is “more likely than not” the Company will be required to sell the security before recovery of its amortized cost basis; or (3) the present value of expected cash flows is not sufficient to recover the entire amortized cost basis.
The Company further estimates the amount of OTTI resulting from a decline in the creditworthiness of the issuer (credit-related OTTI) and the amount of non credit-related OTTI. Non credit-related OTTI can be caused by such factors as market illiquidity. Credit-related OTTI is recognized in earnings while non credit-related OTTI on securities not expected to be sold is recognized in other comprehensive income (loss). The Company did not record OTTI for the three months ended March 31, 2018 and April 1, 2017.
v3.8.0.1
FAIR VALUE MEASUREMENTS
3 Months Ended
Mar. 31, 2018
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS
Financial instruments are categorized as Level 1, Level 2 or Level 3 based upon the method by which their fair value is computed. An investment is categorized as Level 1 when its fair value is based on unadjusted quoted prices in active markets for identical assets that the Company has the ability to access at the measurement date. An investment is categorized as Level 2 if its fair market value is based on quoted market prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, based on observable inputs such as interest rates, yield curves, or derived from or corroborated by observable market data by correlation or other means. An investment is categorized as Level 3 if its fair value is based on assumptions developed by the Company about what a market participant would use in pricing the assets.
The following table details the fair value measurements of the Company’s financial assets:
 
 
 
Fair Value Measurement March 31, 2018 Using:
 
Total
 
Level 1
 
Level 2
 
Level 3
Cash and Cash Equivalents
$
24,167,900

 
$
24,167,900

 
$

 
$

U.S. Government Securities
29,418,278

 
3,987,510

 
25,430,768

 

Corporate Debt
7,255,427

 

 
7,255,427

 

Certificates of Deposit
199,890

 

 
199,890

 

GCS Holdings
459,108

 
459,108

 

 

Equity Investment
3,900,000

 

 

 
3,900,000

Warrant
1,949,816

 

 

 
1,949,816

 
$
67,350,419

 
$
28,614,518

 
$
32,886,085

 
$
5,849,816

 
 
 
 
 
 
 
 
 
 
 
Fair Value Measurement December 30, 2017 Using:
 
Total
 
Level 1
 
Level 2
 
Level 3
Cash and Cash Equivalents
$
24,848,227

 
$
24,848,227

 
$

 
$

U.S. Government Securities
34,725,811

 
6,927,323

 
27,798,488

 

Corporate Debt
8,980,906

 

 
8,980,906

 

Certificates of Deposit
200,740

 

 
200,740

 

GCS Holdings
478,546

 
478,546

 

 

Warrant
2,000,000

 

 

 
2,000,000

 
$
71,234,230

 
$
32,254,096

 
$
36,980,134

 
$
2,000,000

Transfers between levels of the fair value hierarchy are reported at the beginning of the reporting period in which they occur. Changes in Level 3 investments are as follows:
 
December 30, 2017
 
Net unrealized gains/(losses)
 
Purchases, issuances and settlements
 
Transfers in and or out of Level 3
 
March 31, 2018
Equity Investments
$

 
$

 
$
3,900,000

 
$

 
$
3,900,000

Warrant
2,000,000

 
(50,184
)
 

 

 
1,949,816

 
$
2,000,000

 
$
(50,184
)
 
$
3,900,000

 
$

 
$
5,849,816


The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value because of their short-term nature. If accrued liabilities were carried at fair value, these would be classified as Level 2 in the fair value hierarchy.
Marketable Debt Securities
The corporate debt consists of floating rate notes with a maturity that is over multiple years but has interest rates that are reset every three months based on the then-current three-month London Interbank Offering Rate (three-month Libor). The Company validates the fair market values of the financial instruments above by using discounted cash flow models, obtaining independent pricing of the securities or through the use of a model that incorporates the three-month Libor, the credit default swap rate of the issuer and the bid and ask price spread of the same or similar investments which are traded on several markets.
Warrant
The Company has a warrant to acquire up to 15% of the next round of equity offered by a customer as part of the licensing of technology to the customer. The Company used the customer's capital structure, pricing of the shares being offered and the warrant from the customer's qualified financing round in determining the value of its warrant as of March 31, 2018. The Company exercised the warrant in April 2018.
Equity Investment
The Company acquired an interest in an equity investment by transferring $1.0 million cash and certain intellectual property ("IP") in exchange for shares of common stock in the equity investment. The Company used the pricing of the shares being offered to other investors receiving shares of common stock in the same investment as well as a valuation if the IP to determine the value of its equity interest. As the value of the equity investment was determined to be $3.9 million and the carrying value of the IP on the Company’s books was zero, the Company recorded a gain of $2.9 million. The Company adopted ASU No. 2016-01 and the related amendments on December 31, 2017 (the first day of the Company's fiscal year 2018). This standard amends various aspects of the recognition, measurement, presentation, and disclosure of financial instruments. The Company adopted the measurement alternative for equity investments without readily determinable fair values (often referred to as cost method investments) on a prospective basis. As a result, these investments will be revalued upon occurrence of an observable price change for similar investments and for impairments.
v3.8.0.1
INVENTORY
3 Months Ended
Mar. 31, 2018
Inventory Disclosure [Abstract]  
INVENTORY
INVENTORY
Inventories are stated at standard cost adjusted to approximate the lower of cost (first-in, first-out method) or net realizable value and consist of the following at March 31, 2018 and December 30, 2017:
 
March 31, 2018
 
December 30, 2017
Raw materials
$
1,818,727

 
$
2,070,153

Work-in-process
1,335,951

 
1,829,805

Finished goods
618,627

 
1,180,839

 
$
3,773,305

 
$
5,080,797

v3.8.0.1
NET LOSS PER SHARE
3 Months Ended
Mar. 31, 2018
Earnings Per Share [Abstract]  
NET LOSS PER SHARE
NET LOSS PER SHARE
Basic net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period less any unvested restricted shares. Diluted net loss per share is calculated using weighted-average shares outstanding and contingently issuable shares, less weighted-average shares reacquired during the period. The net outstanding shares are adjusted for the dilutive effect of shares issuable upon the assumed conversion of the Company’s common stock equivalents, which consist of outstanding stock options and unvested restricted stock.
The following were not included in weighted-average common shares outstanding-diluted because they are anti-dilutive or performance conditions have not been met at the end of the period:
 
Three Months Ended
 
March 31, 2018
 
April 1, 2017
Non-vested restricted common stock
3,454,274

 
3,067,674

v3.8.0.1
STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION
3 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION
STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION
Non-Vested Restricted Common Stock
The fair value of non-vested restricted common stock awards is generally the market value of the Company’s common stock on the date of grant. The non-vested restricted common stock awards require the employee to fulfill certain obligations, including remaining employed by the Company for one, two or four years (the vesting period) and in certain cases also require meeting either performance criteria or the Company’s stock achieving a certain price. For non-vested restricted common stock awards which solely require the recipient to remain employed with the Company, the stock compensation expense is amortized over the anticipated service period. For non-vested restricted common stock awards which require the achievement of performance criteria, the Company reviews the probability of achieving the performance goals on a periodic basis. If the Company determines that it is probable that the performance criteria will be achieved, the amount of compensation cost derived for the performance goal is amortized over the anticipated service period. If the performance criteria are not met, no compensation cost is recognized and any previously recognized compensation cost is reversed.
Restricted stock activity was as follows:
 
Shares
 
Weighted
Average
Grant
Fair
Value
Balance, December 30, 2017
2,629,274

 
$
3.31

Granted
1,405,000

 
2.17

Forfeited
(560,000
)
 
4.15

Vested
(20,000
)
 
4.22

Balance, March 31, 2018
3,454,274

 
$
2.71


On December 31, 2017, the Company amended the employment agreement with our CEO Dr. John Fan to expire on December 31, 2020 and as part of the amendment issued restricted stock grants. Of the restricted stock grants issued to Dr. Fan, 640,000 shares will vest upon the first 20 consecutive trading day period following the grant date during which the Company's common stock trades at a price equal to or greater than $5.25150,000 shares will vest at the end of the first 20 consecutive trading day period following the grant date during which the Company’s common stock trades at a price per share equal to or greater than $6.00, and 150,000 shares will vest at the end of the first 20 consecutive trading day period following the grant date during which the Company’s common stock trades at a price per share equal to or greater than $7.00. All of the grants are subject to certain acceleration events and expire on December 31, 2020. The total fair value of these awards on December 31, 2017 was $1.7 million. The value of restricted stock grants that vest based on market conditions is computed on the date of grant using the Monte Carlo model with the following assumptions:
 
For the period ended March 31, 2018
Performance price target
$
5.25

 
$
6.00

 
$
7.00

Expected volatility
48.3
%
 
48.3
%
 
48.3
%
Interest rate
1.97
%
 
1.97
%
 
1.97
%
Expected life (years)
3

 
3

 
3

Dividend yield
%
 
%
 
%

Stock-Based Compensation
The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three months ended March 31, 2018 and April 1, 2017 (no tax benefits were recognized):
 
Three Months Ended
 
March 31, 2018
 
April 1, 2017
Cost of product revenues
$
110,226

 
$
104,092

Research and development
274,316

 
218,558

Selling, general and administrative
1,014,873

 
969,455

Total
$
1,399,415

 
$
1,292,105


Unrecognized compensation expense for non-vested restricted common stock as of March 31, 2018 totaled $7.7 million and is expected to be recognized over a weighted average period of approximately two years.
v3.8.0.1
EQUITY INVESTMENTS
3 Months Ended
Mar. 31, 2018
Equity Method Investments and Joint Ventures [Abstract]  
Equity Investments
The Company acquired equity interest in a company in the first quarter of 2018. The Company made a $1.0 million capital contribution during the three months ended March 31, 2018. The Company also contributed certain intellectual property. As of March 31, 2018, the Company owned 12.5% interest in this investment and the carrying value of the Company's investment is $3.9 million.
v3.8.0.1
(Notes)
3 Months Ended
Mar. 31, 2018
Product Warranties Disclosures [Abstract]  
ACCRUED WARRANTY
ACCRUED WARRANTY
The Company typically warrants its products against defect for 12 to 15 months, however, for certain products a customer may purchase an extended warranty. A provision for estimated future costs and estimated returns for credit relating to such warranty is recorded in the period when product is shipped and revenue recognized, and is updated as additional information becomes available. The Company’s estimate of future costs to satisfy warranty obligations is based primarily on historical warranty expense experienced and a provision for potential future product failures. Changes in the accrued warranty for the three months ended March 31, 2018 are as follows:
Balance, December 30, 2017
$
649,000

Additions
64,000

Claims
(114,000
)
Balance, March 31, 2018
$
599,000


Extended Warranties
Deferred revenue represents the purchase of extended warranties by the Company's customers. The Company recognizes revenue from an extended warranty on the straight-line method over the life of the extended warranty, which is typically 12 to 15 months beyond the standard 12-month warranty. The Company classifies the current portion of deferred revenue under other accrued liabilities in its condensed consolidated balance sheets. The Company currently has $0.7 million of deferred revenue related to extended warranties.
v3.8.0.1
INCOME TAXES
3 Months Ended
Mar. 31, 2018
Income Tax Disclosure [Abstract]  
INCOME TAXES
INCOME TAXES
The Company did not record a tax provision for the three months ended March 31, 2018. The Company’s tax provision of approximately $1.1 million for the three months ended April 1, 2017, represents the net benefit of $0.1 million for foreign income taxes including interest income on intercompany loans, uncertain tax positions and a benefit for the net reduction in estimated foreign withholding. In addition, as a result of the acquisition of NVIS, Inc. in the first quarter of 2017, we recognized $1.1 million of deferred tax liabilities which provides evidence of recoverability of our net deferred tax assets that previously carried a full valuation allowance. We reduced the valuation allowance on our net deferred tax assets in the amount of $1.1 million and such reduction was recognized as a benefit for income taxes for the three months ended April 1, 2017. As of March 31, 2018, the Company has available for tax purposes U.S. federal NOLs of approximately $165.0 million expiring 2022 through 2037. The Company has recognized a full valuation allowance on its domestic and certain foreign net deferred tax assets due to the uncertainty of realization of such assets.
Ownership changes, as defined by the Internal Revenue Code, may substantially limit the amount of net operating loss carryforwards that can be utilized annually to offset future taxable income. The ownership change in 2017 did not result in an annual net operating loss limitation as the acquired entity was an S Corporation and did not have loss carryforwards. Subsequent ownership changes could affect the limitation in future years. Such annual limitations could result in the expiration of net operating loss and tax credit carryforwards before utilization.
The tax years 2001 through 2016 remain open to examination by major taxing jurisdictions to which the Company is subject to United States federal tax. These periods have carryforward attributes generated in years past that may still be adjusted upon examination by the Internal Revenue Service or state tax authorities if they have or will be used in a future period. State statutes are generally shorter with shorter carryforward periods. The Company is currently not under examination by the Internal Revenue Service and is currently under examination by Massachusetts for the 2013 tax year. The Company recognizes both accrued interest and penalties related to its uncertain tax positions related to intercompany loan interest and potential transfer pricing exposure related to its Korean subsidiary.
The Company has concluded that it does not maintain its permanent reinvestment assertion with regard to the unremitted earnings of its Korean subsidiary. As such, it accrues U.S. tax for the possible future repatriation of these unremitted foreign earnings. If the Company were to repatriate these earnings, it expects to have foreign withholding at a rate of 16.5% and does not expect any taxes to be paid in the U.S when repatriated as it currently is expected to be a return of capital.
v3.8.0.1
GOODWILL AND INTANGIBLE ASSETS
3 Months Ended
Mar. 31, 2018
Goodwill, Translation and Purchase Accounting Adjustments [Abstract]  
Goodwill and Intangible Assets
A rollforward of the Company's goodwill by segment is as follows:
 
Kopin
 
Industrial
 
Total
Balance, December 30, 2017
$
891,683

 
$
888,564

 
$
1,780,247

Change due to exchange rate fluctuations
21,741

 

 
21,741

Balance, March 31, 2018
$
913,424

 
$
888,564

 
$
1,801,988


The Company recognized $0.2 million of amortization expense for the three months ended March 31, 2018 and April 1, 2017 related to intangible assets. At March 31, 2018 and December 30, 2017, the Company's intangible assets include customer relationships, developed technology and a trade name, which had a total carrying value of $2.5 million, total accumulated amortization of $1.8 million and $1.6 million, respectively, and a total net book value of $0.7 million and $0.9 million, respectively. The intangibles have a remaining life of less than 1 year as of March 31, 2018.
v3.8.0.1
CONTRACT ASSETS AND CONTRACT LIABILITIES (Notes)
3 Months Ended
Mar. 31, 2018
Contract Assets and Contract Liabilities [Abstract]  
Contract Assets (Liabilities), Net [Text Block]
12.     CONTRACT ASSETS AND LIABILITIES
Net contract assets (liabilities) consisted of the following:
 
March 31, 2018
 
December 30, 2017
 
$ Change
 
% Change
Contract assets—current
$
2,479,062

 
$
704,863

 
$
1,774,199

 
252
 %
Contract assets—noncurrent
400,000

 

 
400,000

 
 %
Contract liabilities—current
(384,073
)
 
(896,479
)
 
512,406

 
(57
)%
Contract liabilities—noncurrent
(262,207
)
 
(374,171
)
 
111,964

 
(30
)%
Net contract assets (liabilities)
$
2,232,782

 
$
(565,787
)
 
$
2,798,569

 
(495
)%

The $2.8 million increase in the Company's net contract assets (liabilities) from December 30, 2017 to March 31, 2018 was primarily due to the adoption of Topic 606. The Company did not recognize impairment losses on our contract assets in the first quarters of 2018 and 2017.
v3.8.0.1
SEGMENTS AND GEOGRAPHICAL INFORMATION
3 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
SEGMENTS AND GEOGRAPHICAL INFORMATION
SEGMENTS AND DISAGGREGATION OF REVENUE
The Company’s chief operating decision maker is its Chief Executive Officer. The Company has determined it has two reportable segments, Industrial, which includes the operations that develop and manufacture its reflective display products and virtual reality systems for test and simulation products, and Kopin, which includes the operations that develop and manufacture its other products.
As noted in Note 2. Accounting Standards, effective December 31, 2017, the Company adopted the requirements of Topic 606 using the modified retrospective method. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods.
Segment financial results were as follows:
 
Three months ended
Total Revenue (in thousands)
March 31, 2018
 
April 1, 2017
Kopin
$
2,997

 
$
2,959

Industrial
2,657

 
1,419

Eliminations

 

Total
$
5,654

 
$
4,378

 
 
 
 
 
Three months ended
Total Intersegment Revenue (in thousands)
March 31, 2018
 
April 1, 2017
Kopin
$

 
$

Industrial

 

Total
$

 
$

 
 
 
 
 
Three months ended
Net Loss Attributable to the Controlling Interest (in thousands)
March 31, 2018
 
April 1, 2017
Kopin
$
(5,990
)
 
$
(7,911
)
Industrial
310

 
53

Eliminations
144

 

Total
$
(5,536
)
 
$
(7,858
)
 
 
 
 
 
Three months ended
Intersegment Loss Attributable to the Controlling Interest (in thousands)
March 31, 2018
 
April 1, 2017
Kopin
$

 
$

Industrial
(144
)
 

Total
$
(144
)
 
$

 
 
 
 
Total Assets (in thousands)
March 31, 2018
 
December 30, 2017
Kopin
$
80,742

 
$
82,707

Industrial
6,131

 
8,615

Total
$
86,873

 
$
91,322


Total long-live assets by country for the fiscal years ended March 31, 2018 and December 30, 2017 were as follows:
Total Long-lived Assets (in thousands)
March 31, 2018
 
December 30, 2017
U.S.
$
2,352

 
$
2,456

United Kingdom
186

 
192

China
487

 
338

Japan
193

 
206

Korea
2,086

 
1,885

Total
$
5,304

 
$
5,077


We disaggregate our revenue from contracts with customers by geographic location and by display application, as we believe it best depicts how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors.
During the three months ended March 31, 2018 and April 1, 2017, the Company derived its sales from the following geographies:
 
Three Months Ended March 31, 2018
 
Kopin
 
Industrial
 
Total
(In thousands, except percentages)
Revenue
 
% of Total
 
Revenue
 
% of Total
 
Revenue
 
% of Total
United States
$
2,209

 
39
%
 
$
1,388

 
25
%
 
$
3,597

 
64
%
Other
2

 

 
4

 

 
6

 

        Americas
2,211

 
39

 
1,392

 
25

 
3,603

 
64

Asia-Pacific
480

 
8

 
693

 
12

 
1,173

 
21

Europe
306

 
5

 
569

 
10

 
875

 
15

Middle East

 

 
3

 

 
3

 

       Total Revenues
$
2,997

 
53
%
 
$
2,657

 
47
%
 
$
5,654

 
100
%
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended April 01, 2017
 
Kopin
 
Industrial
 
Total
(In thousands, except percentages)
Revenue
 
% of Total
 
Revenue
 
% of Total
 
Revenue
 
% of Total
United States
$
1,958

 
45
%
 
$
207

 
5
%
 
$
2,165

 
49
%
Asia-Pacific
592

 
14

 
635

 
15

 
1,227

 
28

Europe
409

 
9

 
577

 
13

 
986

 
23

       Total Revenues
$
2,959

 
68
%
 
$
1,419

 
32
%
 
$
4,378

 
100
%

During the three months ended March 31, 2018 and April 1, 2017, the Company derived its sales from the following display applications:
 
Three Months Ended March 31, 2018
 
Three Months Ended April 01, 2017
(In thousands)
Kopin
 
Industrial
 
Total
 
Kopin
 
Industrial
 
Total
Military
$
798

 
$
1,486

 
$
2,284

 
$
854

 
$
483

 
$
1,337

Industrial
748

 
1,011

 
1,759

 
586

 
904

 
1,490

Consumer
891

 

 
891

 
645

 

 
645

R&D
560

 
49

 
609

 
445

 

 
445

Other

 
111

 
111

 
429

 
32

 
461

Total Revenues
$
2,997

 
$
2,657

 
$
5,654

 
$
2,959

 
$
1,419

 
$
4,378

v3.8.0.1
LITIGATION
3 Months Ended
Mar. 31, 2018
Commitments and Contingencies Disclosure [Abstract]  
LITIGATION
LITIGATION
The Company may engage in legal proceedings arising in the ordinary course of business. Claims, suits, investigations and proceedings are inherently uncertain and it is not possible to predict the ultimate outcome of such matters and our business, financial condition, results of operations or cash flows could be affected in any particular period.
BlueRadios, Inc. v. Kopin Corporation, Civil Action No. 16-02052-JLK (D. Col.):
On August 12, 2016, BlueRadios, Inc. ("BlueRadios") filed a complaint in the U.S. District Court for the District of Colorado, alleging that the Company breached a contract between it and BlueRadios concerning a joint venture between the Company and BlueRadios to design, develop and commercialize micro-display products with embedded wireless technology referred to as “Golden-i”, breached the covenant of good faith and fair dealing associated with that contract, breached its fiduciary duty to BlueRadios, and misappropriated trade secrets owned by BlueRadios in violation of Colorado law (C.R.S. § 7-74-104(4)) and the Defend Trade Secrets Act (18 U.S.C. § 1836(b)(1)). BlueRadios further alleges that the Company was unjustly enriched by its alleged misconduct, BlueRadios is entitled to an accounting to determine the amount of profits obtained by the Company as a result of its alleged misconduct, and the inventorship on at least ten patents or patent applications owned by the Company need to be corrected to list BlueRadios’ employees as inventors and thereby list BlueRadios as co-assignees of the patents. BlueRadios seeks monetary, declaratory, and injunctive relief.
On October 11, 2016, the Company filed its Answer and Affirmative Defenses. The parties are in the midst of discovery, with the close of discovery currently set for July 2, 2018. A trial date has not yet been set by the Court. The Company has not concluded a loss from this matter is probable; therefore, we have not recorded an accrual for litigation or claims related to this matter for the period ended March 31, 2018. The Company will continue to evaluate information as it becomes known and will record an estimate for losses at the time or times when it is both probable that a loss has been incurred and the amount of the loss is reasonably estimable.
v3.8.0.1
RELATED PARTY TRANSACTIONS
3 Months Ended
Mar. 31, 2018
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS
The Company may from time to time enter into agreements with shareholders, affiliates and other companies engaged in certain aspects of the display, electronics, optical and software industries as part of our business strategy. In addition, the wearable computing product market is relatively new and there may be other technologies the Company needs to purchase from affiliates in order to enhance its product offering. The Company and Goertek have entered into agreements to jointly develop and commercialize a range of technologies and wearable products. These include: a mutually exclusive supply and manufacturing arrangement for a certain display product for twenty four months after mass production begins; an agreement that provides the Company with the right of first refusal to invest in certain manufacturing capacity for certain products with Goertek; an agreement whereby Goertek will provide system level original equipment manufacturing services for the Company's wearable products; an arrangement whereby the Company will supply display modules for Goertek's virtual reality and augmented reality products; and other agreements related to promotion around certain products as well as providing designs relating to head mounted displays.
During the three month periods ended March 31, 2018, the Company had the following transactions with related parties:
 
Three Months Ended
 
March 31, 2018
 
April 1, 2017
 
Sales
 
Purchases
 
Sales
 
Purchases
Goertek
$

 
$
220,004

 
$

 
$
9,000

RealWear, Inc.
251,351

 

 
62,000

 

 
$
251,351

 
$
220,004

 
$
62,000

 
$
9,000


The Company had the following receivables and payables with related parties:
 
March 31, 2018
 
December 30, 2017
 
Receivables
 
Payables
 
Receivables
 
Payables
Goertek
$

 
$
118,418

 
$

 
$
326,877

RealWear, Inc.
293,071

 

 
414,635

 

 
$
293,071

 
$
118,418

 
$
414,635

 
$
326,877

v3.8.0.1
ACCOUNTING STANDARDS (Policies)
3 Months Ended
Mar. 31, 2018
Revenue, Initial Application Period Cumulative Effect Transition [Abstract]  
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition
The vast majority of our revenues are from orders received from our customers for the purchase of wearable technology components which can be integrated to create headset systems. We also have development contracts for the design, manufacture and modification of products for the U.S. government or a prime contractor for the U.S. government (“U.S. government”) or for a customer that sells into the industrial or consumer markets. The Company's contracts with the U.S. government are typically subject to the Federal Acquisition Regulations (“FAR”) and are priced based on estimated or actual costs of producing goods. The FAR provides guidance on the types of costs that are allowable in establishing prices for goods provided under U.S. government contracts. The pricing for non-U.S. government contracts is based on the specific negotiations with each customer.
Our fixed-price contracts with the U.S. government may result in revenue recognized in excess of amounts actually billed. We present the in excess of revenues over amounts actually billed as Contract assets on the balance sheet. Amounts billed and due from our customers are classified as receivables on the balance sheet. In some instances, the U.S. government retains a small portion of the contract price until completion of the contract. The portion of the payments retained until final contract settlement is not considered a significant financing component because the intent is to protect the customer. For contracts with the U.S. government, we typically receive interim payments either as work progresses, we achieve certain milestones or based on a schedule in the contract. We recognize a liability for these advance payments in excess of revenue recognized and present it as billings in excess of revenue recognized on the balance sheet. The advanced payment typically is not considered a significant financing component because it is used to meet working capital demands that can be higher in the early stages of a contract and to protect us from the other party failing to adequately complete some or all of its obligations under the contract. For industrial and consumer purchase orders, we typically receive payments within 30 to 60 days of shipments of the product, although for some purchase orders, we may require an advanced payment prior to shipment of the product.
To determine the proper revenue recognition method for complex contracts with the same customer, we evaluate whether two or more contracts should be combined and accounted for as one single contract and whether the combined or single contract should be accounted for as more than one performance obligation. This evaluation requires significant judgment and the decision to combine a group of contracts or separate the combined or single contract into multiple performance obligations could change the amount of revenue and profit recorded in a given period. For most of our development contracts and contracts with the U.S government, the customer contracts with us to provide a significant service of integrating a set of components into a single unit. Hence, the entire contract is accounted for as one performance obligation. Less common, however, we may promise to provide distinct goods or services within a contract in which case we separate the contract into more than one performance obligation. If a contract is separated into more than one performance obligation, we allocate the total transaction price to each performance obligation in an amount based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. In cases where we sell standard products, the observable standalone sales are used to determine the standalone selling price.
The Company recognizes revenue from a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. For certain contracts that meet the foregoing requirements, primarily international direct commercial and military sale contracts, we recognize revenue once we have obtained all regulatory approvals.
Commencing in 2018 for certain contracts with the U.S. government, the Company recognizes revenue over time as we perform because of continuous transfer of control to the customer and the lack of an alternative use for the product. The continuous transfer of control to the customer is supported by liability clauses in the contract that allow the U.S. government to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit and take control of any work in process. For contracts with commercial customers while the contract may have similar liability clause our products historically have an alternative use and thus, revenue is recognized at a point in time.
In situations where control transfers over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. We generally use the cost-to-cost approach to measure the extent of progress towards completion of the performance obligation for our contracts because we believe it best depicts the transfer of assets to the customer which occurs as we incur costs on our contracts. Under the cost-to-cost measure approach, the extent of progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation. Revenues are recorded proportionally as costs are incurred.
Accounting for design, development and production contracts requires judgment relative to assessing risks, estimating contract revenues and costs, and making assumptions for schedule and technical issues. Due to the size and nature of the work required to be performed on many of our contracts, the estimation of total revenue and cost at completion is complicated and subject to many variables. Contract costs include material, labor and subcontracting costs, as well as an allocation of indirect costs. We have to make assumptions regarding the number of labor hours required to complete a task, the complexity of the work to be performed, the availability and cost of materials, and performance by our subcontractors. For contract change orders, claims or similar items, we apply judgment in estimating the amounts and assessing the potential for realization. These amounts are only included in contract value when they can be reliably estimated and realization is considered probable. If our estimate of total contract costs or our determination of whether the customer agrees that a milestone is achieved is incorrect, our revenue could be overstated or understated and the profits or loss reported could be wrong.
For our commercial customers, the Company's revenue is recognized when obligations under the terms of a contract with our customer is satisfied; generally this occurs with the transfer of control of the Company's products or services. Revenue is recorded as the amount of consideration we expect to receive in exchange for transferring goods or providing services. Provisions for product returns and allowances are recorded in the same period as the related revenues. We analyze historical returns, current economic trends and changes in customer demand and acceptance of product when evaluating the adequacy of sales returns and other allowances. Certain product sales are made to distributors under agreements allowing for a limited right of return on unsold products. Sales to distributors are primarily made for sales to the distributors' customers and not for stocking of inventory. We delay revenue recognition for our estimate of distributor claims of right of return on unsold products based upon our historical experience with our products and specific analysis of amounts subject to return based upon discussions with our distributors or their customers. Sales, value add and other taxes we collect concurrent with revenue-producing activities are excluded from revenue.
The rights and benefits to the Company's intellectual property are conveyed to certain customers through technology license agreements. These agreements may include other performance obligations including the sale of product to the customer. When the license is distinct from other obligations in the agreement, the Company treats the license and other performance obligations as separate performance obligations. Accordingly, the license is recognized at a point in time or over time based on the standalone selling price. The sale of materials are recognized at a point in time, which occurs with the transfer of control of the Company's products or services. In certain instances, the Company is entitled to sales-based royalties under license agreements. These sales-based royalties are recognized when they are earned.
The cumulative effect of the changes made to the Company's consolidated December 31, 2017 balance sheet for the adoption of ASU 2014-09, Revenue from Contracts with Customers (Topic 606) was as follows:
Balance Sheet
Balance at December 30, 2017
 
Adjustments due to ASC 606
 
Balance at December 31, 2017
Assets
 
 
 
 
 
Contract assets and unbilled receivables
$
704,863

 
$
2,850,274

 
$
3,555,137

Inventory
5,080,797

 
(1,082,629
)
 
3,998,168

Other assets
3,842,068

 
400,000

 
4,242,068

 
 
 
 
 
 
Liabilities
 
 
 
 
 
Contract liabilities and billings in excess of revenue earned
896,479

 
(891,737
)
 
4,742

 
 
 
 
 
 
Stockholders’ equity
 
 
 
 
 
Accumulated Deficit
$
(240,121,901
)
 
$
3,059,382

 
$
(237,062,519
)
In accordance with the new revenue standard requirements, the impact of adoption on the Company's condensed consolidated statement of operations and condensed balance sheets was as follows:
 
For the period ended March 31, 2018
Statement of Operations
As Reported
 
Balances Without Adoption of
ASC 606
 
Effect of Change Higher/(Lower)
Net product revenues
$
5,044,809

 
$
6,505,343

 
$
(1,460,534
)
Research and development revenues
608,811

 
695,355

 
(86,544
)
Cost of product revenues
4,062,191

 
5,069,765

 
(1,007,574
)
Net loss attributable to the controlling interest
$
(5,536,278
)
 
$
(4,996,773
)
 
$
(539,505
)
 
For the period ended March 31, 2018
Balance Sheet
As Reported
 
Balances Without Adoption of
ASC 606
 
Effect of Change Higher/(Lower)
Assets
 
 
 
 
 
Contract assets and unbilled receivables
$
2,479,062

 
$
1,089,322

 
$
1,389,740

Inventory
3,773,305

 
3,848,359

 
(75,054
)
Other assets
4,194,219

 
3,794,219

 
400,000

 
 
 
 
 
 
Liabilities
 
 
 
 
 
Contract liabilities and billings in excess of revenue earned
384,073

 
1,189,266

 
(805,193
)
 
 
 
 
 
 
Stockholders’ equity
 
 
 
 
 
Accumulated deficit
$
(242,598,797
)
 
$
(245,082,132
)
 
$
2,483,335


See Note 11. Segments and Disaggregation of Revenue for additional information regarding the disaggregation of the Company's revenue by major source and the Company's updated accounting policy for revenue recognition.
Contract Assets
Contract assets include unbilled amounts typically resulting from sales under contracts when the cost-to-cost method of revenue recognition is utilized and revenue recognized exceeds the amount billed to the customer, and right to payment is not just subject to the passage of time. Amounts may not exceed their net realizable value. Contract assets are generally classified as current. The Company classifies the noncurrent portion of contract assets under other assets in its condensed consolidated balance sheets.
Contract Liabilities
Contract liabilities consist of advance payments and billings in excess of cost incurred and deferred revenue.
Remaining Performance Obligations
Remaining performance obligations represent the transaction price of firm orders for which work has not been performed and excludes unexercised contract options and potential orders under ordering-type contracts (e.g., indefinite-delivery, indefinite-quantity ("IDIQ")). As of March 31, 2018, the aggregate amount of the transaction price allocated to remaining performance obligations was $2.7 million. The Company expects to recognize revenue on the remaining performance obligations over the next 12 months.
v3.8.0.1
ACCOUNTING STANDARDS (Tables)
3 Months Ended
Mar. 31, 2018
Revenue, Initial Application Period Cumulative Effect Transition [Abstract]  
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]
The cumulative effect of the changes made to the Company's consolidated December 31, 2017 balance sheet for the adoption of ASU 2014-09, Revenue from Contracts with Customers (Topic 606) was as follows:
Balance Sheet
Balance at December 30, 2017
 
Adjustments due to ASC 606
 
Balance at December 31, 2017
Assets
 
 
 
 
 
Contract assets and unbilled receivables
$
704,863

 
$
2,850,274

 
$
3,555,137

Inventory
5,080,797

 
(1,082,629
)
 
3,998,168

Other assets
3,842,068

 
400,000

 
4,242,068

 
 
 
 
 
 
Liabilities
 
 
 
 
 
Contract liabilities and billings in excess of revenue earned
896,479

 
(891,737
)
 
4,742

 
 
 
 
 
 
Stockholders’ equity
 
 
 
 
 
Accumulated Deficit
$
(240,121,901
)
 
$
3,059,382

 
$
(237,062,519
)
In accordance with the new revenue standard requirements, the impact of adoption on the Company's condensed consolidated statement of operations and condensed balance sheets was as follows:
 
For the period ended March 31, 2018
Statement of Operations
As Reported
 
Balances Without Adoption of
ASC 606
 
Effect of Change Higher/(Lower)
Net product revenues
$
5,044,809

 
$